Stephens raised the firm’s price target on Emerson (EMR) to $155 from $145 and keeps an Equal Weight rating on the shares, driven partly by raised estimates and partly on recent orders strength, which the firm says bodes well beyond FY26.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on EMR: